Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-06 8:23 pm |
Senti Biosciences Inc. | SNTI | Lu Timothy K CEO |
4,467 | $4.1054 | $18,339 | 187,760 (Indirect Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 7:53 pm |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
1,479 | $4.1069 | $6,074 | 8,621 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-10 Conversion |
2025-03-14 11:52 am |
N/A N/A |
Senti Biosciences Inc. | SNTI | Celadon Partners SPV 24 10% Owner |
9,786,777 | $0 | 9,777,000 (Direct) |
View |
Ownership |
2025-03-13 4:32 pm |
2025-03-06 N/A |
Senti Biosciences Inc. | SNTI | Celadon Partners SPV 24 10% Owner |
0 | $0 | 24,442,500 (Direct) |
View |
| 2025-03-10 Conversion |
2025-03-12 9:30 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Florence Anthony A. Jr. Makhzoumi Mohamad SANDELL SCOTT D 10% Owner |
3,336,333 | $0 | 3,775,615 (Direct) |
View |
Ownership |
2025-03-12 9:20 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | New Enterprise Associates 15 L.P. NEA Partners 15 L.P. NEA 15 GP LLC BASKETT FOREST Makhzoumi Mohamad Florence Anthony A. Jr. SANDELL SCOTT D 10% Owner |
0 | $0 | 3,789,326 (Direct) |
View |
| 2025-03-10 Conversion |
2025-03-12 8:31 pm |
2025-03-10 N/A |
Senti Biosciences Inc. | SNTI | BAYER HEALTHCARE LLC Bayer US Holding LP Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner |
2,224,222 | $0 | 6,139,848 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:28 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2025-03-10 Conversion |
2025-03-11 4:23 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
33,000 | $2.25 | 119,984 (Indirect) |
View |
| 2025-03-10 Conversion |
2025-03-11 4:23 pm |
2025-03-10 N/A |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
33 | $2,250 | 119,984 (Indirect) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:21 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Schulz Fran Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:20 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:20 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Tang Donald F Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:20 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | COOPERSTONE BRENDA Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:17 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Hsiung Feng Director |
43,900 | $0 | 43,900 (Direct) |
View |
| 2025-03-07 Option Award |
2025-03-11 4:14 pm |
N/A 2035-03-06 |
Senti Biosciences Inc. | SNTI | Cross John Harry III Chief Financial Officer |
174,200 | $0 | 174,200 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 7:02 pm |
N/A 2034-12-19 |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
313,451 | $0 | 322,072 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 7:01 pm |
N/A 2034-12-19 |
Senti Biosciences Inc. | SNTI | Lu Timothy K CEO and Interim PFO and PAO |
2,569,431 | $0 | 2,757,191 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:19 pm |
N/A 2034-12-08 |
Senti Biosciences Inc. | SNTI | Tang Donald F Director |
12,500 | $0 | 12,500 (Direct) |
View |
Ownership |
2024-12-10 4:18 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | Tang Donald F Director |
0 | $0 | 10,368 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:17 pm |
N/A 2034-12-08 |
Senti Biosciences Inc. | SNTI | Schulz Fran Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:15 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
49,500 | $0 | 49,533 (Indirect) |
View |
| 2024-12-09 Option Award |
2024-12-10 4:15 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Pres. & Chief Med. & Dev. Off. |
33 | $2,250 | 49,533 (Indirect) |
View |
| 2024-07-10 Option Award |
2024-07-12 4:30 pm |
N/A 2034-07-09 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2024-07-10 Option Award |
2024-07-12 4:17 pm |
N/A 2034-07-09 |
Senti Biosciences Inc. | SNTI | Farokhzad Omid Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2024-07-10 Option Award |
2024-07-12 4:16 pm |
N/A 2034-07-09 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2024-07-10 Option Award |
2024-07-12 4:15 pm |
N/A 2034-07-09 |
Senti Biosciences Inc. | SNTI | COOPERSTONE BRENDA Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:29 pm |
N/A 2034-01-31 |
Senti Biosciences Inc. | SNTI | Rajangam Kanya Chief Medical & Devt. Officer |
253,000 | $0 | 253,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:27 pm |
N/A 2034-01-31 |
Senti Biosciences Inc. | SNTI | Lu Timothy K CEO and President |
765,000 | $0 | 2,381,276 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:24 pm |
N/A 2034-01-31 |
Senti Biosciences Inc. | SNTI | KNOBELMAN DEBORAH Chief Financial Officer |
253,000 | $0 | 283,000 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:24 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | Mathers Edward T Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:14 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | Berland Susan D Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:13 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | Collins James J. Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:12 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | COOPERSTONE BRENDA Director |
62,500 | $0 | 62,500 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-21 7:10 pm |
N/A 2033-06-15 |
Senti Biosciences Inc. | SNTI | Farokhzad Omid Director |
62,500 | $0 | 62,500 (Direct) |
View |
Ownership |
2023-02-13 4:40 pm |
N/A N/A |
Senti Biosciences Inc. | SNTI | BAYER HEALTHCARE LLC Bayer US Holding LP Bayer World Investments B.V. BAYER AKTIENGESELLSCHAFT 10% Owner |
0 | $0 | 5,878,488 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-02 5:21 pm |
N/A 2033-01-31 |
Senti Biosciences Inc. | SNTI | Lee Philip J Chief Technology Officer |
195,000 | $0 | 195,000 (Direct) |
View |